5462 related articles for article (PubMed ID: 3501419)
21. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
[TBL] [Abstract][Full Text] [Related]
22. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
23. [Management of primary malignant melanoma of the skin in German-speaking countries 1983-1993. A study of the Malignant Melanoma Central Register of the German Society of Dermatology].
Garbe C; Büttner P; Ellwanger U; Orfanos CE
Hautarzt; 1995 Nov; 46(11):762-70. PubMed ID: 8641882
[TBL] [Abstract][Full Text] [Related]
24. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
[TBL] [Abstract][Full Text] [Related]
25. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
27. [Basic principles of melanoma surgery].
Walz MK
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():111-4. PubMed ID: 9101793
[TBL] [Abstract][Full Text] [Related]
28. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
29. [Pregnancy, hormone preparations and malignant melanoma].
Garbe C
Hautarzt; 1993 Jun; 44(6):347-52. PubMed ID: 8335457
[TBL] [Abstract][Full Text] [Related]
30. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
31. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
32. Prognostic variables for patients with stage III malignant melanoma.
Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
[TBL] [Abstract][Full Text] [Related]
33. [Significant prognostic factors for recurrence-free survival after surgical treatment of head-neck melanoma].
Andersson AP; Gottlieb J; Søndergaard K; Hou-Jensen K; Drzewiecki KT
Ugeskr Laeger; 1993 Aug; 155(31):2397-9. PubMed ID: 8346590
[TBL] [Abstract][Full Text] [Related]
34. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
35. [Metastases of skin melanoma from unknown primary site].
Khasanov ShR; Iavorskiĭ VV; Demidov LV
Vopr Onkol; 1987; 33(3):36-9. PubMed ID: 3564370
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
37. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
Averbook BJ; Russo LJ; Mansour EG
Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
40. Malignant melanoma in pregnancy. A population-based evaluation.
O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
